Target intelligence / Profile preview

Tripartite motif-containing protein 21 (TRIM21)

Target
TRIM21
Molecular classification
E3 ubiquitin-protein ligase, TRIM family protein, RING-finger protein, Intracellular Fc receptor
01

Overview

Tripartite motif-containing protein 21 (TRIM21) is a multifunctional cytosolic E3 ubiquitin ligase and a high-affinity intracellular Fc receptor for IgG, IgM, and IgA [1, 2]. It serves as a critical component of the intracellular innate immune system by detecting and neutralizing antibody-coated viruses and bacteria that have escaped extracellular defenses and entered the cytoplasm [2]. Upon binding the Fc region of an antibody, TRIM21 undergoes auto-ubiquitination and recruits the 26S proteasome to rapidly degrade the entire antibody-pathogen complex, a mechanism termed antibody-dependent intracellular neutralization (ADIN) [2, 3]. Additionally, TRIM21 regulates inflammatory signaling by modulating the stability of interferon regulatory factors (IRFs) such as IRF3, IRF5, and IRF7, thereby influencing the production of type I interferons [4]. Clinically, TRIM21 is well-known as the Ro52 autoantigen, with anti-Ro52 antibodies serving as key diagnostic biomarkers for systemic lupus erythematosus and Sjögren's syndrome [1, 5]. In drug development, TRIM21 is the central effector in "Trim-Away" technology, which utilizes exogenous antibodies to trigger the targeted degradation of endogenous proteins, offering a potential therapeutic avenue for diseases driven by "undruggable" proteins [3]. [1] UniProt Consortium. (2023). P19474 (TRIM21_HUMAN). [2] Mallery, D. L., et al. (2010). Antibodies mediate intracellular immunity through tripartite motif-containing protein 21 (TRIM21). PNAS. [3] Clift, D., et al. (2017). A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell. [4] Espinosa, A., et al. (2009). The Sjögren's syndrome antigen Ro52/TRIM21 regulates T cell function and cytokine production. Journal of Immunology. [5] Schulte-Pelkum, J., et al. (2009). Clinical significance of anti-Ro52 antibodies. Clin Rev Allergy Immunol.

Other names
Ro52SSA1RNF8152 kDa Ro protein52 kDa ribonucleoprotein autoantigen Ro/SS-ASjögren syndrome antigen A1
02

Mechanism of action

TRIM21 is targeted primarily through the recruitment of its E3 ubiquitin ligase activity to degrade specific proteins via antibody-binding (Trim-Away) or through the modulation of its role in interferon signaling and autoantibody recognition.

03

Biological functions

Intracellular antibody-mediated proteolysisUbiquitin-mediated protein degradationInnate immune signaling regulationType I interferon productionPro-inflammatory cytokine regulation
04

Disease associations

Sjögren's syndromeSystemic lupus erythematosusViral infectionCancerInflammatory myopathy
05

Safety considerations

Potential for systemic inflammatory responsesInduction of autoimmunityOff-target degradation of essential proteins in Trim-Away applicationsDysregulation of innate immune signaling
06

Interacting drugs

Antibodies (used in Trim-Away technology)

1 more in the full profile.

07

Biomarkers

Anti-Ro52 autoantibodiesAnti-SSA autoantibodiesTRIM21 mRNA expression levels

Beyond the preview

Go deeper on Tripartite motif-containing protein 21 (TRIM21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif-containing protein 21 (TRIM21).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call